Concepedia
Statistics
Publications
41
Citations
2.5K
H-Index
27
Active since
1998
Affiliations
Biogen (United States)(Current)
Eli Lilly (United States)
State University of New York
Stony Brook University
University of North Carolina at Chapel Hill
Stephen J. Demarest is an author at Biogen (United States) specializing in antibody engineering, life sciences, and biochemistry.
Publications per year
1998–2024
Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators
Stephen J. Demarest, Maria A. Martinez‐Yamout, John Y. L. Chung et al. · Nature · 2002 · 459 citations
Life Sciences, Biochemistry, Molecular Biology +14
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M. Lewis, Xiufeng Wu, Anna Pustilnik et al. · Nature Biotechnology · 2014 · 241 citations
Pharmacy, Biotechnology, Immunology +16
A broad range of Fab stabilities within a host of therapeutic IgGs
Ellen A. Garber, Stephen J. Demarest · Biochemical and Biophysical Research Communications · 2007 · 235 citations
Pharmacy, Biochemistry, Molecular Pharmaceutics +9
Antibody therapeutics, antibody engineering, and the merits of protein stability.
Stephen J. Demarest, Scott Glaser · PubMed · 2008 · 131 citations
Pharmacy, Biochemistry, Biotechnology +17
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
Brian Miller, Stephen J. Demarest, Alexey A. Lugovskoy et al. · Protein Engineering Design and Selection · 2010 · 127 citations
Pharmacy, Biotechnology, Molecular Biology +17
1–5 of 41